169 related articles for article (PubMed ID: 35501867)
1. Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia.
Bi L; Jia S; Hu W; Su X; Chen X; Tang H
BMC Med Genomics; 2022 May; 15(1):101. PubMed ID: 35501867
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
4. The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.
Han C; He S; Wang R; Gao X; Wang H; Qiao J; Meng X; Li Y; Yu L
J Transl Med; 2021 Feb; 19(1):65. PubMed ID: 33579308
[TBL] [Abstract][Full Text] [Related]
5. Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia.
Wei J; Huang XJ; Huang Y; Xiong MY; Yao XY; Huang ZN; Li SN; Zhou WJ; Fang DL; Deng DH; Cheng P
Ann Transl Med; 2021 Sep; 9(17):1386. PubMed ID: 34733938
[TBL] [Abstract][Full Text] [Related]
6. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
7. Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue.
Walter SA; Cutler RE; Martinez R; Gishizky M; Hill RJ
J Biol Chem; 2003 May; 278(20):18221-8. PubMed ID: 12639966
[TBL] [Abstract][Full Text] [Related]
8. IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia.
He X; Li W; Liang X; Zhu X; Zhang L; Huang Y; Yu T; Li S; Chen Z
Cell Physiol Biochem; 2018; 51(4):1945-1956. PubMed ID: 30513526
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
[TBL] [Abstract][Full Text] [Related]
10. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Lai Y; Sheng L; Wang J; Zhou M; OuYang G
Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic genes in the acute myeloid leukemia microenvironment.
Huang S; Zhang B; Fan W; Zhao Q; Yang L; Xin W; Fu D
Aging (Albany NY); 2019 Nov; 11(22):10557-10580. PubMed ID: 31740623
[TBL] [Abstract][Full Text] [Related]
12. High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia.
Mu D; Long S; Guo L; Liu W
Technol Cancer Res Treat; 2021; 20():15330338211065877. PubMed ID: 34894858
[No Abstract] [Full Text] [Related]
13. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
14. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
15. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
Xu ZJ; Jin Y; Zhang XL; Xia PH; Wen XM; Ma JC; Lin J; Qian J
Cancer Med; 2023 Jan; 12(1):789-807. PubMed ID: 35642341
[TBL] [Abstract][Full Text] [Related]
17. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker replication factor C subunit 5 and its correlation with immune infiltrates in acute myeloid leukemia.
Li WJ; Wu DW; Zhou YF; Zhang CW; Liao XW
Hematology; 2022 Dec; 27(1):555-564. PubMed ID: 35544695
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of cytogenetics in aged patients with acute myeloid leukemia].
Lin J; Zhu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):587-90. PubMed ID: 25948230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
